业界动态国内医卫资讯
FDA批准度伐利尤单抗联合恩诺单抗维多汀用于肌层浸润性膀胱癌
Medscape News · 2026-11-14 05:23
摘要
随着该批准,对于不适合顺铂的肌层浸润性膀胱癌患者,围手术期帕博利珠单抗联合恩诺单抗维多汀有了一个竞争对手。Medscape Medical News
English
FDA Approves Durvalumab With Enfortumab Vedotin for MIBC
With the approval, there's a rival to perioperative pembrolizumab with enfortumab vedotin for patients with cisplatin-ineligible muscle-invasive bladder cancer. Medscape Medical News